Clinical Read2026-06-30
PH-762
Phio PharmaceuticalsPHIO
- Indication
- Cutaneous squamous cell carcinoma (cSCC)
- Stage
- Phase 1b
- Event
- Phase 1b Data readout
- Details
Date not specified — The provided content appears to be a navigation/menu fragment from an investor relations page (“Press Releases,” “Events & Presentations,” “Stock Information,” “Corporate Governance,” “Financial Information,” “Email Alerts”) and does not include any readable press release/article text. No company name, study/trial/product/event details, results, or business announcements are present in the supplied material, so no substantive summary can be generated from it.
- Source
- View catalyst source ↗
Financial Snapshot
Market Cap
$12.7M
Price
$1.08